Our Mission
Our mission is to efficiently co-develop innovative drugs for the world’s major markets by providing seasoned professionals, clinical trial resources, at-risk funding and expertise.
We accelerate our Partners’ pipelines to provide life-changing treatments to patients and providers worldwide.
- Fills operational and funding gaps
- Provides bridge to increased ex-U.S. value
- Assumes 100% of clinical development risk
- Augments expertise
- Accelerates follow-on indications
- Tailors payback to financial objectives
Via Co-Development Partnerships, SFJ Seeks To:
- Maximize the Value of Partner’s Assets
- Increase Partner’s Shareholder Value
- Increase Number of Partner’s Opportunities
- Reduce Partner’s Portfolio Risk
- Increase Partner’s Operational Capacity
- Accelerate Partner’s Clinical Development Timelines
- Expand Partner’s Geographical Reach
- Provide Non-Dilutive Late-Stage Development Funding
- Optimize Partner’s Financial Reporting